Recent Finacing
Recent Raise
BillionToOne is a molecular diagnostics company that uses QCT single-molecule DNA counting to offer UNITY noninvasive prenatal screening and Northstar liquid-biopsy assays for oncology treatment selection and monitoring.
Focus Areas
Recent Investors
Valuation as of 06/22/2024
Total Raised
Funding rounds
Investors
See the team members at BillionToOne.
